Drugs that inhibit calcineurin or NFAT may also treat diseases in which the beta cells produce too much insulin, such as hypoglycaemia or some pancreatic tumours.
The researchers said drugs that enhance the activity of calcineurin or NFAT could become a new treatment for type-2 diabetes, in which the beta cells do not produce enough insulin.